Home / Stocks / ACH

Accendra Health (ACH, Health Care Distributors) Stock Valuation & Fair Value Fairly valued

Accendra Health (ACH, Health Care Distributors) trades at a blended P/E of 2.9, about 79% below its historical normal valuation, with a forward growth estimate of 3.4% and a PEG of 0.85. Analysts' one-year estimates have been hit 27% of the time.

No quality score is published for this company, which is normal for insurers, banks and REITs. This rating reflects valuation, forecast return and analyst accuracy only. Ratings that cite business quality require one.

DATA AS OF 2026-09-21
Blended P/E
2.9
Normal P/E
14.2
PEG
0.85
Fwd growth
3.4%
Div yield
0.0%
RSI (14)
21.4
Oversold

The Street vs SeerForecast

Wall Street's mean price target for ACH is $1.51 across 5 analysts, 101.3% above the current price. The average analyst rating is Hold. Our SeerForecast read of the same stock, formed without analyst targets: fairly valued. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating has been fairly valued since 2026-08-07.

Blended P/E and rating by weekBlended P/E moved from 4.7 to 2.9 between 2026-08-07 and 2026-09-21, against a normal P/E of 14.2, with 0 rating changes over 16 recorded weeks.2026-08-07: P/E 4.7, Fairly valued (recalculated)2026-08-10: P/E 4.5, Fairly valued2026-08-14: P/E 4.5, Fairly valued (recalculated)2026-08-17: P/E 2.4, Fairly valued2026-08-21: P/E 2.4, Fairly valued (recalculated)2026-08-24: P/E 3.1, Fairly valued2026-08-27: P/E 3.1, Fairly valued (recalculated)2026-08-28: P/E 3.1, Fairly valued (recalculated)2026-08-30: P/E 3.1, Fairly valued (recalculated)2026-08-31: P/E 3.3, Fairly valued2026-09-05: P/E 3.3, Fairly valued (recalculated)2026-09-07: P/E 3.5, Fairly valued2026-09-12: P/E 3.5, Fairly valued (recalculated)2026-09-14: P/E 3.3, Fairly valued2026-09-19: P/E 3.3, Fairly valued (recalculated)2026-09-21: P/E 2.9, Fairly valued5.010.0Aug 7Aug 18Aug 29Sep 10Sep 21Normal P/E 14.2
Attractively valuedFairly valuedAbove fair valueLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

Selected weeks: the first, the latest, and the cheapest and dearest.

WeekBlended P/EPremium to normal P/ERating
2026-08-07P/E 4.7-67%Fairly valued
2026-08-17P/E 2.4-83%Fairly valued
2026-09-21P/E 2.9-79%Fairly valued ← now

Frequently asked questions

Is Accendra Health stock overvalued?

At a blended P/E of 2.9 versus its historical normal P/E of 14.2, Accendra Health trades about 79% below its typical valuation, with a PEG of 0.85 on 3.4% forward growth. tickerseer currently rates it fairly valued.

What is Accendra Health's fair value and PEG?

Accendra Health trades at a blended P/E of 2.9 against a historical normal P/E of 14.2, a PEG of 0.85, and a forward growth estimate of 3.4%.

Has tickerseer's rating of Accendra Health changed?

tickerseer's rating has been fairly valued since 2026-08-07.

What is the analyst price target for Accendra Health?

The mean Wall Street price target for Accendra Health is $1.51 across 5 analysts, 101.3% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Health Care Distributors. Create a free account to see the full analysis: the SeerAI score, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track ACH free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.